1. Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35
2. Cummings J, Smyth JF (1989) Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. Cancer Chemother Pharmacol 24: 269
3. Drake FH, Hofmann GA, Mong S-M, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK (1989) In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res 49: 2578
4. Dykes DJ, Waud WR, Harrison SD Jr, Laster WR Jr, Griswold DP Jr, Shealy YF, Montgomery JA (1989) Antitumor activity of 2-chloroethyl (methylsulfonyl) methanesulfonate (Clomesone, NSC 338947) against selected tumor systems in mice. Cancer Res 49: 1182
5. Estey E, Hoth D, Simon R, Marsoni S, Leyland-Jones B, Wittes R (1986) Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep 70: 1105